Drug Monitoring Assess Panel, Plus, Quantitative, Urine
Use
A definitive panel using liquid chromatography–mass spectrometry (LC/MS/MS) to identify multiple specific drugs and metabolites across drug classes, enhancing patient care. Useful for ensuring therapeutic compliance and detecting diversion or misuse. Use of urine (or oral fluid) is preferred for routine monitoring; serum/plasma only for anuretic patients or if clinical findings don’t match prescriptions. Quantitative urine values should not be used to infer dosing due to metabolism and excretion variables.
Special Instructions
Not provided.
Limitations
Quantitative values cannot be used to assess drug dose due to extensive metabolism and urinary excretion. No single monitoring strategy suffices; laboratory results should be combined with other tools to interpret drug use patterns.
Methodology
Mass Spectrometry
Biomarkers
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
10 mL
Minimum Volume
9 mL
Container
plastic urine container
Causes for Rejection
Preserved urine
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 5 days |
| Refrigerated | 7 days |
| Frozen | 30 days |